MARYANN WEITZ: Open Payments
NPI 1679297865 · NORWELL, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,308 in 27 payments from 17 companies in 2025. Trend: 2023 $712 · 2024 $971 · 2025 $3,308
Consulting: $2,662Food & beverage: $598Education: $48
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $2,694 |
| Karyopharm Therapeutics Inc. | 1 | $109 |
| AstraZeneca Pharmaceuticals LP | 2 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| Genentech USA, Inc. | 2 | $60 |
| GlaxoSmithKline, LLC. | 2 | $57 |
| Legend Biotech USA Inc. | 3 | $48 |
| Syndax Pharmaceuticals, Inc. | 1 | $25 |
| Caris MPI, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: SARCLISA, XPOVIO, CARVYKTI, LYNPARZA, Fabhalta, Gazyva, BLENREP, Polivy.
Industry payments across MA — which companies pay providers there.
